Latest / The Startup Exit Podcast with Fexingo: IPOs, Acquisitions, and Founder Liquidity Events / How Glean Hit 300M in Revenue by Selling AI Cost Cutting
Transcript
- Lucas: Glean just crossed $300 million in annual recurring revenue. That's a big number on its own, but the more interesting story is how they got there — because their main selling point has completely flipped. Luna: I saw that headline. They're basically selling AI cost-cutting now, right? Lucas: Exactly. Two years ago, Glean was the enterprise search tool that helped employees find documents and answers across Slack, email, and Salesforce. The pitch was productivity — 'save time, find information faster.' Now? The pitch is 'we'll reduce your AI bill by 30 percent or more.' And it's working. Luna: That's a pretty dramatic repositioning. What changed? Lucas: The market changed. Companies went all-in on AI in 2023 and 2024 — buying ChatGPT Enterprise licenses, building custom models, deploying agents. But by late 2025, CFOs started looking at those line items and asking, 'Wait, we're spending $10 million a year on AI tools and nobody can measure the ROI.' That's where Glean stepped in. Luna: So they turned a problem — AI overspend — into their wedge. Smart. Lucas: Right. And here's the specific mechanism: Glean's platform sits on top of a company's existing AI tools and usage data. It identifies redundant subscriptions, underused models, and duplicate capabilities. Then it recommends consolidating onto fewer, more efficient models. For one enterprise client, they found the company was paying for four different AI writing assistants. Glean cut it down to one, saving $2.4 million a year. Luna: That's a concrete number. And I bet that kind of saving gets a CFO's attention a lot faster than 'employees will save three minutes per search.' Lucas: Exactly. Productivity gains are soft and hard to prove. Cutting $2.4 million is a hard number you can take to the board. And that's why Glean's top line accelerated — they went from about $180 million ARR last year to $300 million now. That's nearly 67 percent growth in a market where most SaaS companies are decelerating. Luna: And it's not just Glean. This feels like a broader shift. We've seen ARKG — the genomics ETF — jump nearly 12 percent in the last five days. Some of that is probably ai adjacent, because genomics companies are using AI for drug discovery and they're also starting to talk about cost efficiency. Lucas: Yeah, ARKG is up 11.8 percent this week alone. That's a huge move for an ETF. And you're right — it's partly because investors are re-evaluating ai adjacent sectors that can show concrete ROI. Genomic companies that use AI to shorten drug development timelines are starting to demonstrate real cost savings, not just hypothetical future potential. Luna: So the market is rewarding companies that can translate AI into dollar saved, not just 'we have an AI strategy.' Lucas: Exactly. And for founders thinking about an exit — whether it's an acquisition or an IPO — this is a critical lesson. The companies that get premium valuations right now are the ones that can point to a specific, measurable economic impact. Glean's $300 million ARR is impressive, but what makes it an acquisition target or IPO candidate is that they've proven they can sell into a pain point that's getting worse, not better. Luna: And that pain point — AI budget waste — is only going to grow. I read a Gartner projection that by 2027, 60 percent of enterprises will have at least one AI tool they're paying for but not using. Lucas: Exactly. So Glean's addressable market is expanding. And that's the kind of narrative that gets bankers excited. But there's a risk here too — if Glean becomes known primarily as a cost-cutting tool, what happens when the AI spending cycle turns? When companies consolidate and reduce spend, eventually they'll hit a floor. Luna: Right, they need to keep expanding the product. Maybe move from cost-cutting to optimization — helping companies allocate AI spend more effectively across different use cases, not just eliminate waste. Lucas: That's a smart read. And we're already seeing hints of that. Their latest product update includes an AI budget planning module that lets companies model different spending scenarios. So they're evolving from a cost-cutting tool into a financial planning platform for AI. That's a much bigger TAM. Luna: And it positions them as a strategic partner rather than just a vendor. That's the kind of relationship that leads to bigger contracts and longer retention. Lucas: Exactly. And if you're a founder listening, I think there's a direct lesson here: don't be afraid to pivot your positioning based on what the market is actually feeling. Glean started as a productivity tool. They saw the AI spending boom and the inevitable backlash, and they repositioned themselves as the antidote. That took guts, and it's paying off. Luna: And it's not just about the product — it's about the narrative. When you go to raise your next round or talk to acquirers, the story you tell matters as much as the numbers. Glean's story is 'we solve the number one problem that keeps CFOs up at night.' Lucas: That's a perfect framing. And speaking of stories that matter — if these conversations are useful for what you're building or running, we want to keep them coming. This show is ad-free and listener-supported, which means the people who get value from it are the ones who make it possible. If that's you, you can help keep the lights on at buy me a coffee dot com slash fexingo. Everything goes straight into production, research, and hosting. And honestly, it means a lot. Luna: Yeah, it really does. We put a lot of work into every episode, and knowing folks find it worth supporting keeps us going. So thanks to anyone who chips in. Lucas: Alright, back to Glean. One more thing I think is worth noting: Glean's revenue mix is shifting. Two years ago, 80 percent of their revenue came from seat-based subscriptions. Now, about 40 percent comes from usage-based pricing tied to the number of AI queries processed. That's important because it aligns their incentives with their customers — if Glean helps a customer cut AI spend, the customer uses fewer queries, so Glean's revenue goes down in the short term. But in the long term, they retain the customer and expand into other modules. Luna: That's a bold model. Most SaaS companies would resist usage-based pricing because it introduces volatility. But Glean is betting that the trust it builds will lead to higher lifetime value. Lucas: And the early data supports that. Their net revenue retention is over 130 percent, which means existing customers are spending more over time, even with the usage-based component. That's a strong signal that the model works. Luna: So if you're a founder thinking about your own exit, what's the one takeaway from Glean's story? Lucas: I'd say: find the pain that's getting worse, not the one that's already solved. Glean didn't invent AI cost waste — they just showed up with a solution right when the pain peaked. Timing is everything. If you can position your company as the answer to a problem that's growing, your exit opportunities multiply. Luna: And be willing to change your story. Even if it means leaving behind the original vision. Lucas: Exactly. Glean's original vision was 'search for the enterprise.' That's a good business. But 'AI budget optimization for the enterprise' is a great business. They made the leap. And now they're at $300 million ARR with a clear path to a billion. Luna: And with the market rewarding that kind of clarity, I wouldn't be surprised if we see an IPO filing from them within the next 18 months. Lucas: I think you're right. And we'll be watching. For now, that's it on Glean. Next episode, we'll look at another company that's redefining its market — and maybe its exit strategy. See you then.